Proficio Capital Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,060
Closed -$381K – 713
2026
Q2
$381K Buy
+1,060
New +$324K 0.01% 417
2019
Q3
– Sell
-190
Closed -$24K – 1560
2019
Q2
$24K Buy
190
+8
+4% +$944 0.01% 623
2019
Q1
$20K Hold
182
– – 0.01% 655
2018
Q4
$18K Hold
182
– – 0.01% 579
2018
Q3
$22K Buy
182
+8
+5% +$897 0.01% 570
2018
Q2
$17K Buy
174
+9
+5% +$828 0.01% 657
2018
Q1
$15K Hold
165
– – ﹤0.01% 687
2017
Q4
$16K Sell
165
-9
-5% -$882 0.01% 658
2017
Q3
$17K Sell
174
-18
-9% -$1.63K 0.01% 642
2017
Q2
$17K Sell
192
-8
-4% -$736 0.01% 658
2017
Q1
$19K Buy
200
+171
+590% +$14.3K 0.01% 637
2016
Q4
$2K Buy
+29
New +$2.28K ﹤0.01% 949

Other funds holding WST

Proficio Capital Partners's WST Position: Q3 2026 in Review

Proficio Capital Partners sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 1,060 shares — an estimated $381K sold.

Proficio Capital Partners first reported a position in WST in Q4 2016 and held it in 12 quarters. The position peaked at $381K in Q2 2026. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Proficio Capital Partners reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Proficio Capital Partners sold 1,060 West Pharmaceutical shares in Q3 2026, an estimated $381K.
  • Proficio Capital Partners first reported a position in West Pharmaceutical in Q4 2016 and held it in 12 quarters.
  • Proficio Capital Partners's West Pharmaceutical position peaked at $381K in Q2 2026.
  • 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Proficio Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.